Literature DB >> 17490858

Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure.

David E Gard1, Ann M Kring, Marja Germans Gard, William P Horan, Michael F Green.   

Abstract

Research on anhedonia in schizophrenia has revealed mixed results, with patients reporting greater anhedonia than healthy controls on self-report measures and semi-structured interviews, but also reporting comparable experiences of positive emotions in response to pleasurable stimuli. Basic science points to the importance of distinguishing between anticipatory and consummatory (or in-the-moment) pleasure experiences, and this distinction may help to reconcile the mixed findings on anhedonia in schizophrenia. In two studies, we tested the hypothesis that anhedonia in schizophrenia reflects a deficit in anticipatory pleasure but not consummatory pleasure. In Study 1, we used experience sampling methodology to assess reported experiences of consummatory and anticipated pleasure among schizophrenia patients and controls. In Study 2, schizophrenia patients and controls completed a self-report trait measure of anticipatory and consummatory pleasure and interviews that assessed negative symptoms, including anhedonia, and community functioning. In both studies, we found evidence for an anticipatory but not a consummatory pleasure deficit in schizophrenia. In addition, anticipatory pleasure was related to clinical ratings of anhedonia and functional outcome. Clinical and research implications of these findings are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17490858      PMCID: PMC1986826          DOI: 10.1016/j.schres.2007.03.008

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  23 in total

1.  Anticipation of increasing monetary reward selectively recruits nucleus accumbens.

Authors:  B Knutson; C M Adams; G W Fong; D Hommer
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

Review 2.  Brain reward circuitry: insights from unsensed incentives.

Authors:  Roy A Wise
Journal:  Neuron       Date:  2002-10-10       Impact factor: 17.173

3.  Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.

Authors:  Georg Juckel; Florian Schlagenhauf; Michael Koslowski; Dimitri Filonov; Torsten Wüstenberg; Arno Villringer; Brian Knutson; Thorsten Kienast; Jürgen Gallinat; Jana Wrase; Andreas Heinz
Journal:  Psychopharmacology (Berl)       Date:  2006-05-24       Impact factor: 4.530

Review 4.  Parsing reward.

Authors:  Kent C Berridge; Terry E Robinson
Journal:  Trends Neurosci       Date:  2003-09       Impact factor: 13.837

Review 5.  Getting formal with dopamine and reward.

Authors:  Wolfram Schultz
Journal:  Neuron       Date:  2002-10-10       Impact factor: 17.173

Review 6.  Anhedonia in schizophrenia: a review of assessment strategies.

Authors:  William P Horan; Ann M Kring; Jack J Blanchard
Journal:  Schizophr Bull       Date:  2005-10-12       Impact factor: 9.306

7.  Plasma homovanillic acid in untreated schizophrenia--relationship with symptomatology and sex.

Authors:  Z J Zhang; M Peet; C N Ramchand; S Shah; G P Reynolds
Journal:  J Psychiatr Res       Date:  2001 Jan-Feb       Impact factor: 4.791

8.  Exploration of somatosensory P50 gating in schizophrenia spectrum patients: reduced P50 amplitude correlates to social anhedonia.

Authors:  Sidse M Arnfred; Andrew C N Chen
Journal:  Psychiatry Res       Date:  2004-02-15       Impact factor: 3.222

9.  On the broad applicability of the affective circumplex: representations of affective knowledge among schizophrenia patients.

Authors:  Ann M Kring; Lisa Feldman Barrett; David E Gard
Journal:  Psychol Sci       Date:  2003-05

10.  Negative symptoms in first episode non-affective psychosis.

Authors:  Ashok K Malla; Jatinder J Takhar; Ross M G Norman; Rahul Manchanda; Leonard Cortese; Raj Haricharan; Mary Verdi; Rashid Ahmed
Journal:  Acta Psychiatr Scand       Date:  2002-06       Impact factor: 6.392

View more
  262 in total

1.  Negative symptoms and the formation of social affiliative bonds in schizophrenia.

Authors:  Julie M McCarthy; Kristen R Bradshaw; Lauren T Catalano; Cristina P Garcia; Asia Malik; Melanie E Bennett; Jack J Blanchard
Journal:  Schizophr Res       Date:  2017-08-02       Impact factor: 4.939

Review 2.  A new perspective on anhedonia in schizophrenia.

Authors:  Gregory P Strauss; James M Gold
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

3.  Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status.

Authors:  Philip D Harvey; Martin Strassnig
Journal:  World Psychiatry       Date:  2012-06       Impact factor: 49.548

4.  The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.

Authors:  Eri Nakagami; Maanse Hoe; John S Brekke
Journal:  Schizophr Bull       Date:  2010-05-12       Impact factor: 9.306

5.  The brief negative symptom scale: psychometric properties.

Authors:  Brian Kirkpatrick; Gregory P Strauss; Linh Nguyen; Bernard A Fischer; David G Daniel; Angel Cienfuegos; Stephen R Marder
Journal:  Schizophr Bull       Date:  2010-06-17       Impact factor: 9.306

Review 6.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

Review 7.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

8.  Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studies.

Authors:  Alan Anticevic; Jared X Van Snellenberg; Rachel E Cohen; Grega Repovs; Erin C Dowd; Deanna M Barch
Journal:  Schizophr Bull       Date:  2010-12-01       Impact factor: 9.306

9.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

10.  Effects of a GWAS-Supported Schizophrenia Variant in the DRD2 Locus on Disease Risk, Anhedonia, and Prefrontal Cortical Thickness.

Authors:  Margarita V Alfimova; Nikolay V Kondratyev; Alexander S Tomyshev; Irina S Lebedeva; Tatyana V Lezheiko; Vasiliy G Kaleda; Lilia I Abramova; Vera E Golimbet
Journal:  J Mol Neurosci       Date:  2019-05-03       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.